Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.52 USD | +7.32% | -13.51% | +74.26% |
Apr. 29 | Aquestive Therapeutics Obtains FDA Approval for Libervant to Treat Seizure in Children | MT |
Apr. 29 | Transcript : Aquestive Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+74.26% | 320M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- AQST Stock
- News Aquestive Therapeutics, Inc.
- Wedbush Upgrades Aquestive Therapeutics to Outperform Rating From Neutral, Adjusts Price Target to $4 From $3